Vanderbilt Magazine – Featured
Jul. 23, 2020—VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease.
Jul. 1, 2020—In a wide-ranging interview, Chancellor Daniel Diermeier discusses growing up as a first-generation student in a divided Germany, taking the helm during the COVID-19 pandemic, and the collaborative culture that has fueled Vanderbilt’s success.
And the Beat Goes On: A resilient Vanderbilt community finds innovative ways to thrive amid the challenges of COVID-19
May. 14, 2020—As the COVID-19 pandemic continues to upend lives in countless ways, members of the Vanderbilt community have shown remarkable resilience in the face of the crisis.
May. 14, 2020—Vanderbilt Magazine raises a glass of its own to the tenacious, accomplished and always adaptable Class of 2020. Cheers to you all.
May. 14, 2020—From the front lines of patient care to collaborating with scientists across the globe searching for treatments and vaccines, Vanderbilt University Medical Center and Vanderbilt University researchers have been working for months to combat the COVID-19 pandemic.